Australia's therapeutic goods market is one of the most regulated—and most rewarding—globally. With a population that actively seeks high-quality health products and a regulatory framework that ensures consumer confidence, Australia presents a compelling opportunity for international supplement brands. But here's the challenge: the Therapeutic Goods Administration (TGA) has strict requirements for market entry, especially for …
Australia’s therapeutic goods market is one of the most regulated—and most rewarding—globally. With a population that actively seeks high-quality health products and a regulatory framework that ensures consumer confidence, Australia presents a compelling opportunity for international supplement brands.
But here’s the challenge: the Therapeutic Goods Administration (TGA) has strict requirements for market entry, especially for non-resident sponsors. Unlike the U.S. FDA’s DSHEA framework or the EU’s EFSA system, Australia treats many dietary supplements as “listed medicines,” requiring formal registration before sale.
This guide breaks down the TGA entry process specifically for non-resident brands sourcing from Chinese OEM/ODM partners like Zuoning Bio, helping you navigate compliance from formulation to shelf.
Understanding TGA’s Regulatory Framework
The TGA regulates therapeutic goods under the Therapeutic Goods Act 1989. Most dietary supplements fall under the “complementary medicines” category and are regulated as either:
- Listed Medicines (AUST L): Lower-risk products with pre-approved ingredients and established indications. Most vitamin, mineral, and herbal supplements fall here.
- Registered Medicines (AUST R): Higher-risk products requiring comprehensive safety and efficacy evaluation. Rarely applicable to standard supplements.
For non-resident brands, the Listed Medicines pathway is the most practical and cost-effective route.
The Sponsor Requirement: Your First Hurdle
Here’s the critical point many international brands miss: every therapeutic good in Australia must have a sponsor.
The sponsor is the legal entity responsible for:
- Holding the product listing on the Australian Register of Therapeutic Goods (ARTG)
- Ensuring ongoing compliance with TGA standards
- Managing adverse event reporting and recalls
- Responding to TGA queries and inspections
Non-resident brands have two options:
- Establish an Australian subsidiary — register an Australian company and act as your own sponsor
- Appoint a local sponsor — engage an Australian-based company to act as your regulatory representative
For brands testing the market or scaling gradually, option 2 is often the fastest route. Zuoning Bio works with several Australian sponsors who can manage the registration process, allowing you to focus on marketing and distribution.
Step-by-Step: TGA Listed Medicine Registration Process
Step 1: Ingredient Eligibility Check
Before formulation finalization, verify that all active ingredients appear on the TGA’s Permissible Ingredients Determination. This list specifies:
- Approved ingredient names and synonyms
- Maximum daily doses
- Required warning statements
- Prohibited combinations
If your formula contains an ingredient not on the list, you’ll need to either reformulate or submit a substantial evaluation—adding significant time and cost.
OEM Partner Checklist: Does your manufacturer have experience with TGA-permissible formulations? Can they provide documentation showing ingredient compliance?
Step 2: Manufacturing Standards Verification
The TGA requires all manufacturing sites to comply with Good Manufacturing Practice (GMP) standards. For Chinese manufacturers, this typically means:
- GMP certification recognized by TGA (via Mutual Recognition Agreement or direct audit)
- ISO 22000 or HACCP certification as baseline quality systems
- Documentation of manufacturing processes, quality control, and batch release procedures
Zuoning Bio maintains GMP-compliant facilities with documentation packages ready for TGA review, streamlining this verification step.
Step 3: Prepare Your Listing Application
Your sponsor (or your Australian entity) will submit the listing application through TGA’s electronic system. Required information includes:
- Product details: Name, dosage form, route of administration
- Formulation: Complete ingredient list with quantities per dose
- Labeling: Draft labels meeting TGA requirements
- Manufacturing information: Site addresses, GMP certificates
- Evidence dossier: Scientific support for any indications claimed
Step 4: Label Compliance
TGA labeling requirements are specific and differ from U.S. or EU standards. Key elements include:
- AUST L number: Must appear on the front panel
- Permissible indications only: Use only TGA-approved indications; no disease treatment claims
- Mandatory warning statements: As specified in the Permissible Ingredients Determination
- Sponsor details: Australian address and contact information
- Batch number and expiry date: For traceability
Common Pitfall: Many brands assume FDA-compliant labels will satisfy TGA. They won’t. The AUST L number, warning statements, and indication restrictions require separate label design.
Step 5: Submit and Receive ARTG Entry
Once submitted, TGA processing typically takes 20–30 working days for straightforward listings. The sponsor receives an ARTG entry number, and the product is legally marketable in Australia.
Post-Market Obligations
TGA compliance doesn’t end at registration. Sponsors must:
- Maintain GMP compliance at all manufacturing sites
- Report adverse events within required timeframes
- Respond to TGA requests for information or samples
- Update ARTG entries for any formulation changes
- Conduct periodic stability testing and retain records
Common Mistakes to Avoid
- Skipping the sponsor step — Attempting to sell directly without an Australian legal entity or representative
- Using unapproved ingredients — Assuming “natural” means permissible; always check the Determination
- Copying FDA labels — TGA requires different warnings, the AUST L number, and approved indications only
- Ignoring GMP documentation — Your OEM partner must provide verifiable quality system records
- Making disease claims — TGA strictly prohibits disease treatment or prevention claims for Listed Medicines
How Zuoning Bio Supports Your TGA Entry
As your OEM/ODM partner, Zuoning Bio provides:
- Pre-formulation ingredient screening against TGA Permissible Ingredients
- GMP-compliant manufacturing with documentation packages ready for TGA review
- Label design support ensuring TGA compliance
- Stability and COA documentation meeting Australian requirements
- Coordination with Australian sponsors to streamline registration
- Export documentation for smooth customs clearance
Ready to Enter the Australian Market?
Australia’s TGA-regulated market offers strong consumer confidence and growth potential—but only if you enter correctly. By understanding the sponsor requirement, ensuring ingredient eligibility, and partnering with a compliant manufacturer, your brand can successfully navigate the TGA pathway.
Contact Zuoning Bio today to discuss your TGA-compliant supplement formulation.
Wade@zuoningbio.com | +86 187 5469 6289 | www.zuoningbio.com




